🟢 Kailera Therapeutics is trading 10% up today after consecutive declines

Kailera Therapeutics is trading 10% up at $16.94 after rebounding from consecutive declines.

• Shares fell 5% on August 31, 2026.
• No clear company-specific announcement or catalyst has been identified for the September 1, 2026 move.
• The broader market and biotechnology sector are under pressure and do not directly explain the same-direction rebound; the move remains an unexplained intraday recovery.